IR News
Stay up-to-date with the latest investor relations news.
Remedi sets IPO price at the top band of KRW 20,700… Demand forecast competition ratio reaches 1,146:1
Published On 2026.06.26
Remedi: “Accelerating growth into a next-generation X-ray platform company spanning medical and industrial sectors
Published On 2026.06.19
Remedi–Data4Life sign MOU for global tuberculosis eradication data sharing and joint clinical research
Published On 2026.05.29
Remedi files securities registration statement… begins KOSDAQ listing process.
Published On 2026.05.22